The Current Ratio as of September 2024 (TTM) for Perspective Therapeutics, Inc. (CATX) is 2.67

According to Perspective Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.67. This represents a change of -68.04% compared to the average of 8.36 of the last 4 quarters.

Perspective Therapeutics, Inc. (CATX) Historical Current Ratio (quarterly & annually)

How has CATX Current Ratio performed in the past?

The mean historical Current Ratio of Perspective Therapeutics, Inc. over the last ten years is 14.98. The current 2.67 Current Ratio has changed 1.68% with respect to the historical average. Over the past ten years (40 quarters), CATX's Current Ratio was at its highest in in the June 2021 quarter at 37.37. The Current Ratio was at its lowest in in the September 2023 quarter at 2.67.

Perspective Therapeutics, Inc. (CATX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Perspective Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Perspective Therapeutics, Inc. (CATX) Average Current Ratio

How has CATX Current Ratio performed in the past?

The current Current Ratio of Perspective Therapeutics, Inc. (CATX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Perspective Therapeutics, Inc. (CATX) Current Ratio vs. Peers

How is CATX’s Current Ratio compared to its peers?

Perspective Therapeutics, Inc.’s Current Ratio is less than OrthoPediatrics Corp. (4.90), greater than Orthofix Medical Inc. (2.48), less than Sight Sciences, Inc. (11.01), less than NeuroPace, Inc. (6.37), less than CVRx, Inc. (10.08), greater than PAVmed Inc. (0.57), greater than ProSomnus, Inc. Common Stock (0.30), less than Hyperfine, Inc. (8.08), less than Electromed, Inc. (5.75), less than Surmodics, Inc. (3.98), less than Paragon 28, Inc. (3.57), less than LivaNova PLC (3.45), less than Pulmonx Corporation (8.96), less than SI-BONE, Inc. (9.17),

Build a custom stock screener for Perspective Therapeutics, Inc. (CATX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Perspective Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Perspective Therapeutics, Inc. (CATX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Perspective Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.